Your browser doesn't support javascript.
loading
Adverse drug reactions associated with doxorubicin and epirubicin: A descriptive analysis from VigiBase.
Matesun, Deborah A; Mensah, Kofi Boamah; Yamoah, Peter; Bangalee, Varsha; Padayachee, Neelaveni.
Affiliation
  • Matesun DA; Department of Pharmacy and Pharmacology, Faculty of Health Sciences, 37707University of the Witwatersrand, Johannesburg, South Africa.
  • Mensah KB; Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Science, College of Health Science, 98763Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
  • Yamoah P; Discipline of Pharmaceutical Sciences, 72753College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Bangalee V; School of Pharmacy, 549574University of Health and Allied Sciences, Ho, Ghana.
  • Padayachee N; College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
J Oncol Pharm Pract ; : 10781552221113578, 2022 Jul 13.
Article in En | MEDLINE | ID: mdl-35833221

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2022 Type: Article Affiliation country: South Africa

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2022 Type: Article Affiliation country: South Africa